Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges in Community-Based Interprofessional Care Teams
Released On
January 5, 2024
Expires On
December 20, 2024
Media Type
Internet
Completion Time
60 Minutes
Specialty
Hematology-Oncology, Pathology, Pharmacy
Topic(s)
Lymphoma, Oncology
Sponsored by the Annenberg Center for Health Sciences.
This activity is supported by independent educational grants from Genentech, a member of the Roche Group, and Novartis Pharmaceuticals .
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
- Physician Assistants — 1.0 AAPA Category 1 CME Credit
- Pharmacists — 1.0 CPE Hours
- Nurses — 1.0 American Nurses Credentialing Center (ANCC) Contact Hour, including 1.0 pharmacology hour
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
Developed to support the educational needs of hematologist-oncologists, hematology-oncology advanced practice providers, pathologists, and pharmacists who manage patients with follicular lymphoma.
Program Overview
This clinical activity highlights the significant disease burden of follicular lymphoma, specifically in patients requiring multiple lines of therapy, as well as the latest advances in therapeutics and practical strategies for integrating novel therapies into practice through patient selection, supportive care management, and interprofessional collaboration and communication.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe disease burden and unmet clinical needs experienced by patients with follicular lymphoma.
- Review current treatment landscape and updates for newly diagnosed and relapsed/refractory follicular lymphoma.
- Incorporate recent efficacy and safety data for newly approved and emerging therapies for relapsed/refractory follicular lymphoma into treatment planning.
- Develop interprofessional management strategies surrounding complications associated with novel agents including monitoring, toxicity management, and transitions of care.
Faculty
Jeremy S. Abramson, MD, MMSc
Director, Lymphoma Program
Jon and Jo Ann Hagler Chair in Lymphoma
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Accreditation Statement
In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Associate Credit
The Annenberg Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
Pharmacist Credit
The Annenberg Center designates this knowledge-based activity for a maximum of 1.0 hour. Credit will be provided to NABP CPE Monitor within 45 days after the activity is completed.
Nurse Credit
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.0 contact hour.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Disclosures of Conflicts of Interest
- Jeremy S. Abramson, MD
- Consultant: AbbVie, AstraZeneca, BMS, BeiGene, Epizyme, Genentech, Genmab, Interius, Janssen, Kite Pharma, Lilly, Takeda
- Research Support: BMS, Cellectis, Merck, Mustang Bio, Seagen
Additional content planners
- Christopher Elder, PharmD, BCOP (Medical Writer)
- Advisory Board: Eisai, Genentech, Mirati, Novartis, Pfizer, Pharmacosmos, Sanofi
The following have no significant relationship to disclose:
Kimberly Brennan Tyler, MS, RN, ANP-C, AOCNP (Nurse Reviewer)
Annenberg Center for Health Sciences:
All staff at the Annenberg Center have no relevant financial relationships to disclose.
All the relevant financial relationships listed for these individuals have been mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.
Disclaimer
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center for Health Sciences at Eisenhower disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
Contact Information
For CME questions please contact: [email protected].